SEC Form 4 · accession 0000899243-17-018430
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Bramlage
Director
Period of report
Jul 14, 2017
Accepted (ET)
Jul 18, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Jul 14, 2017 | A | 30,000 | A | — | Aug 13, 2018 | Common Stock | 30,000 | 30,000 | D |
| Stock OptionsF2 | $2.64 | Jul 14, 2017 | A | 15,000 | A | — | Jul 14, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The restricted stock units ("RSUs") were issued to the Reporting Person on July 14, 2017, as compensation for service on the Issuer's board of directors. The RSUs vest as follows: (i) 15,000 RSUs vest in the first open window following the filing of the Company's quarterly 10Q for June 30, 2017 and (b) 15,000 RSUs vest in the first open window following the Company's 2018 Annual Meeting of Stockholders.
- F2The stock options ("options") were issued to the Reporting Person on July 14, 2017, as compensation for service on the Issuer's board of directors. The options vest as follows: (i) 7,500 options vest in the first open window following the filing of the Company's quarterly 10Q for June 30, 2017 and (b) 7,500 options vest in the first open window following the Company's 2018 Annual Meeting of Stockholders.